{"id":"https://openalex.org/W2071978545","doi":"https://doi.org/10.2174/0929867043364775","title":"Clinical Applications of MAO-Inhibitors","display_name":"Clinical Applications of MAO-Inhibitors","publication_year":2004,"publication_date":"2004-08-01","ids":{"openalex":"https://openalex.org/W2071978545","doi":"https://doi.org/10.2174/0929867043364775","mag":"2071978545","pmid":"https://pubmed.ncbi.nlm.nih.gov/15279566"},"language":"en","primary_location":{"id":"doi:10.2174/0929867043364775","doi":"https://doi.org/10.2174/0929867043364775","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867043364775","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2071978545"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069476421","display_name":"Peter Franz Riederer","orcid":"https://orcid.org/0000-0002-3453-6335","observed_orcids":["https://orcid.org/0000-0002-3453-6335"]},"institutions":[{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"P. Riederer","raw_affiliation_strings":["Clinical Neurochemistry, Dept. Psychiatry, Univ. Wuerzburg, Wuerzburg, Germany. peter.riederer@mail.uni-wuerzburg.de","Clinical Neurochemistry, Dept. Psychiatry, Univ. Wuerzburg, Wuerzburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neurochemistry, Dept. Psychiatry, Univ. Wuerzburg, Wuerzburg, Germany. peter.riederer@mail.uni-wuerzburg.de","institution_ids":["https://openalex.org/I25974101"]},{"raw_affiliation_string":"Clinical Neurochemistry, Dept. Psychiatry, Univ. Wuerzburg, Wuerzburg, Germany","institution_ids":["https://openalex.org/I25974101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112357229","display_name":"L. Lachenmayer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Lachenmayer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5061831529","display_name":"Gerd Laux","orcid":"https://orcid.org/0000-0002-6373-9334","observed_orcids":["https://orcid.org/0000-0002-6373-9334"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Laux","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.5081,"has_fulltext":false,"cited_by_count":227,"citation_normalized_percentile":{"value":0.95940669,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"11","issue":"15","first_page":"2033","last_page":"2043"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.15449999272823334,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.14159999787807465,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibitors","display_name":"monoamine oxidase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/selegiline","display_name":"selegiline","score":0.8849999904632568},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7089999914169312},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.8389999866485596},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8379999995231628},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9919999837875366},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.8339999914169312},{"id":"https://openalex.org/keywords/moclobemide","display_name":"moclobemide","score":0.9300000071525574},{"id":"https://openalex.org/keywords/rasagiline","display_name":"rasagiline","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5830000042915344},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.9480000138282776},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/amphetamine-metabolites","display_name":"amphetamine metabolites","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C2776134090","wikidata":"https://www.wikidata.org/wiki/Q47495783","display_name":"Selegiline","level":4,"score":0.9604882001876831},{"id":"https://openalex.org/C2780237459","wikidata":"https://www.wikidata.org/wiki/Q421934","display_name":"Moclobemide","level":4,"score":0.92600417137146},{"id":"https://openalex.org/C2781249495","wikidata":"https://www.wikidata.org/wiki/Q420685","display_name":"Rasagiline","level":4,"score":0.7406303882598877},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.653753399848938},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.6034519672393799},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5466046333312988},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.500136137008667},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.4859939515590668},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.4411994218826294},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.36484143137931824},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.3522934019565582},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.34865641593933105},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3225272297859192},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.24178054928779602},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20183059573173523},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.15741842985153198},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.13597318530082703},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08923855423927307},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.06927084922790527},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/0929867043364775","doi":"https://doi.org/10.2174/0929867043364775","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867043364775","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:15279566","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15279566","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2162175064","https://openalex.org/W2787324869","https://openalex.org/W255271375","https://openalex.org/W203989212","https://openalex.org/W2049531984","https://openalex.org/W149902436","https://openalex.org/W2013684533","https://openalex.org/W2021429428","https://openalex.org/W149100819"],"abstract_inverted_index":{"Monoamine":[0],"oxidase":[1],"inhibitors":[2,173],"(MAO-I)":[3],"have":[4],"been":[5],"useful":[6],"in":[7,148,151,156,188],"the":[8,22,32,73,89,92,131],"treatment":[9],"of":[10,24,34,64,96,106,127,139,165,181,183,201],"both":[11],"psychiatric":[12],"and":[13,44,56,61,72,118,144,169,191,197],"neurological":[14],"disorders":[15],"over":[16],"centuries.":[17],"Here":[18],"we":[19],"focus":[20,112],"on":[21,31,40,88,113,130,194,198],"development":[23],"this":[25],"drug":[26],"treatment.":[27],"Focus":[28],"is":[29,75,79,98,109,146,179],"given":[30],"use":[33],"irreversible":[35],"MAO-I's":[36,184],"as":[37,39,158,177],"well":[38],"reversible":[41],"ones.":[42],"Benefit":[43],"side":[45],"effects":[46,63,126],"are":[47,70,154,160,175],"reported":[48],"for":[49,82],"Parkinson's":[50],"disease,":[51],"Alzheimer's":[52],"dementia,":[53],"depression":[54],"syndrome":[55],"panic":[57],"disorders.":[58],"The":[59],"preclinical":[60],"clinical":[62,84,195],"selegiline":[65],"with":[66,167,185],"regard":[67],"to":[68,116,122,142],"neuroprotection":[69],"highlightened":[71],"conclusion":[74],"drawn":[76],"that":[77,91],"there":[78,159,178],"good":[80],"evidence":[81],"a":[83,102,111,136],"neuroprotective":[85],"capacity":[86],"based":[87],"assumption":[90],"50":[93],"percent":[94],"recovery":[95],"MAO-B":[97],"obtained":[99],"already":[100],"after":[101],"10":[103],"days":[104],"withdrawal":[105],"selegiline.":[107],"There":[108],"also":[110],"selegilines":[114],"metabolism":[115,141],"amphetamine":[117,143],"metamphetamine.":[119],"In":[120],"order":[121],"avoid":[123,138],"any":[124],"such":[125],"metabolic":[128],"compounds":[129,187],"cardiovascular":[132],"system":[133],"Zydis":[134],"Selegiline,":[135],"melt-tablet":[137],"major":[140],"metamphetamine":[145],"described":[147,176],"detail.":[149],"Developments":[150],"MAO-I":[152],"research":[153],"discussed":[155],"detail":[157],"moclobemide,":[161],"lacabemide,":[162],"rasagiline.":[163],"Interactions":[164],"MAO-I'":[166],"tricyclics":[168],"serotonin":[170],"selective":[171],"reuptake":[172],"(SSRI's)":[174],"mentioning":[180],"interactions":[182],"other":[186],"general.":[189],"Tables":[190],"figures":[192],"report":[193],"studies":[196],"pharmacological":[199],"properties":[200],"MAO-I's.":[202]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
